Dihydroquinolinone derivatives

US8609847B2 · kind B2 · utility

Assignee

• TAISHO PHARMACEUTICAL CO., LTD. · JP

Inventors

• Toshio Nakamura · Toshima, JP
• Seiji Masuda · Toshima, JP
• Aya Futamura · Tokyo, JP

Key dates

• Filing date: Feb 5, 2010
• Grant date: Dec 17, 2013
• Expiry date: Jul 15, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a prophylactic or therapeutic agent for dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression, allergic rhinitis or other diseases.A dihydroquinolinone derivative represented by formula (1) or a pharmaceutically acceptable salt thereof:{wherein Q represents the following formula (A) or (B)}